The July 2019 (Q2) Category M price changes have been published, with eight additions and five deletions.
• 20 have more than doubled in price compared to April (with 8 more than trebling)
• 50 items have been reduced in price by at least 20% (with 9 falling more than 50%)
• 8 items have been added
• 5 items have been deleted
There are currently 632 active items on the list, out of a total of 677 that have appeared on the list since April 2017.
Excluding the new product entries to the list, the top five price increases are:
|Drug||Pack size||April price (£)||Price rise in July (£)|
|Sevelamer 800mg tablets||180||55.44||82.14|
|Ibandronic acid 50mg tablets||28||26.30||41.70|
|Dosulepin 75mg tablets||28||4.88||10.87|
|Amiloride 5mg tablets||28||3.29||8.60|
|Naproxen 500mg gastro-resistant tablets||56||14.1||7.16|
The five products with the greatest price reductions between the April Q1 and July Q2 lists are:
|Drug||Pack size||April price (£)||Price change in July (£)|
|Liothyronine 20microgram tablets||28||206.71||-23.31|
|Carbimazole 20mg tablets||100||92.01||-21.71|
|Levetiracetam 100mg/ml oral solution sugar free||300||28.94||-16.27|
|Risperidone 4mg tablets||60||32.74||-7.91|
|Propylthiouracil 50mg tablets||56||24.50||-7.34|
DDA members can view the full spreadsheet, sorted by price history, price order, price change and price percentage change by visiting the library of Category M Updates in the Dispensary Management Zone.